A comprehensive genomic analysis of breast cancer (Cancer Genome Atlas, 2012) cells previously identified the transcription factors, FOXM1 and c-myc, which are hyperactivated in TNBCs as factors to contribute to the downregulation of the CD95 expression (Penke et al., 2018; Zhang et al., 2017). The gene discussed is FOXM1; the disease is breast carcinoma.